QuickVue SARS Antigen Test

Available from Jant Pharmacal Corp
Product Menu
View Company Profile View all Products

Product Details

The QuickVue SARS Antigen Test is a lateral flow immunoassay that allows for the rapid, qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in anterior nares (NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

For additional information visit our website.

Rate and Review Jant Pharmacal Corp - QuickVue SARS Antigen Test

No reviews yet.

Let users know what you would have wanted to know about this company.